Preventing perinatal transmission of HIV: your vigilance can pay off.
Tolle
Michael A
MA
Baylor College of Medicine, Texas Children's Hospital, Baylor International Pediatric AIDS Initiative, Houston, TX 77030, USA. tolle@bcm.edu
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001942:Breast Feeding; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011263:Pregnancy Trimester, Third; D011295:Prenatal Care / Q000592:standards; D018570:Risk Assessment; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D015215:Zidovudine